Immunogenicity of Pfizer-BioNTech COVID-19 vaccine in patients with inborn errors of immunity

BACKGROUND: In mid-December 2020, Israel started a nationwide mass vaccination campaign against coronavirus disease 2019 (COVID-19). In the first few weeks, medical personnel, elderly citizens, and patients with chronic diseases were prioritized. As such, patients with primary and secondary immunode...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:J Allergy Clin Immunol
Glavni autori: Hagin, David, Freund, Tal, Navon, Michal, Halperin, Tami, Adir, Dikla, Marom, Rotem, Levi, Inbar, Benor, Shira, Alcalay, Yifat, Freund, Natalia T.
Format: Artigo
Jezik:Inglês
Izdano: American Academy of Allergy, Asthma & Immunology 2021
Teme:
Covid-19
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC8168345/
https://ncbi.nlm.nih.gov/pubmed/34087242
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jaci.2021.05.029
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items